Capital raised by Iambic Therapeutics
1 Form D filing · first filed Apr 2026 · San Diego, CA
Chief Executive Officer
Signatory on Iambic Therapeutics's Form D filings · $27.8M raised across 1
Thomas Miller is on file as Chief Executive Officer at Iambic Therapeutics in San Diego, CA. Iambic Therapeutics has 1 Form D filing on record, $27.8M raised in total. Thomas Miller appears as a signatory on the company's filings.
LinkedIn profileAn AI platform for small-molecule drug design built around two core models: NeuralPLexer, a co-folding model for predicting protein and protein-ligand structures, and Enchant, a multimodal transformer for predicting molecular properties. The models are integrated with automated chemical synthesis and experimental execution so novel designs are turned into biological data each week.